Chemoinformaics analysis of 6-Prenylnaringenin
Molecular Weight | 340.375 | nRot | 3 |
Heavy Atom Molecular Weight | 320.215 | nRig | 6 |
Exact Molecular Weight | 340.131 | nRing | 3 |
Solubility: LogS | -1.526 | nHRing | 1 |
Solubility: LogP | 2.399 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
nHA | 5 | APOL | 50.7459 |
nHD | 3 | BPOL | 22.6681 |
QED | 0.558 |
Synth | 1.514 |
Natural Product Likeliness | 0.032 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0.122 |
HIA | 0.003 |
CACO-2 | -4.363 |
MDCK | 0.0000272 |
BBB | 0.737 |
PPB | 0.849822 |
VDSS | 0.944 |
FU | 0.115877 |
CYP1A2-inh | 0.862 |
CYP1A2-sub | 0.95 |
CYP2c19-inh | 0.583 |
CYP2c19-sub | 0.727 |
CYP2c9-inh | 0.135 |
CYP2c9-sub | 0.826 |
CYP2d6-inh | 0.589 |
CYP2d6-sub | 0.908 |
CYP3a4-inh | 0.055 |
CYP3a4-sub | 0.382 |
CL | 15.381 |
T12 | 0.869 |
hERG | 0.01 |
Ames | 0.087 |
ROA | 0.243 |
SkinSen | 0.636 |
Carcinogencity | 0.602 |
EI | 0.995 |
Respiratory | 0.627 |
NR-Aromatase | 0.011 |
Antiviral | Yes |
Prediction | 0.789727 |